We’re here for the entrepreneurs

May 12, 2017

Next Generation Microbial Therapeutics: Transforming the Therapeutic Landscape for Atopy & Asthma

Lunch Seminar, Amgen Innovator Series

Nikole E. Kimes, PhD
Co-Founder & VP, Siolta Therapeutics

Siolta Therapeutics is designing microbial therapeutics aimed at the prevention and treatment of inflammatory diseases. They are currently focused on the rational design of a mixed-species therapeutic microbial consortium to treat airway inflammation. Ultimately working towards a future in which the microbiome can help drive patient stratification and tailored microbial therapeutics.

About Nikole Kimes

Nikole Kimes, PhD, is Co-Founder and Vice President of Siolta Therapeutics. Nikole’s was trained as an environmental and human microbial ecologist – most recently as a postdoctoral scholar in the laboratory of Dr. Susan Lynch at UCSF, which provided the foundation for Siolta Therapeutics. Her efforts at Siolta leverage microbiota data to improve patient stratification and develop microbial therapeutics to re-engineer microbiome composition and metabolic function in the gastrointestinal tract.

Upcoming Event

  • San Carlos Open House

    Come to meet MBC BioLabs residents, tour our new space in San Carlos, and hear about our exciting plans for the future. There will be posters from our companies, a live band, and an opportunity to chat with our partners and staff. RSVP In just 4 years, we have helped 116 entrepreneurial teams create fast, focused and frugal biotech companies that have gone on to raise $2.4 billion and counting. With this new facility, we can empower more entrepreneurs with the space and resources they need to tackle world changing science. Come join us in celebrating our newest MBC Biolabs campus and welcome our residents and partners!


953 Indiana St., San Francisco, CA 94107
Tel: (415)-347-8287

Sign-Up for our Newsletter